Bystolic, A Novel Beta Blocker, Is Now Approved By The FDA For The Treatment Of Hypertension (Medical News Today)
Forest Laboratories, Inc. (NYSE: FRX) and Mylan Inc. (NYSE: MYL) announced that the novel beta blocker Bystolic (nebivolol) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of hypertension. Bystolic is a once daily medication that can be used alone or in combination with other hypertension treatments. [click link for full article]

Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC (T-Net British Columbia)
Vancouver, BC, December 18, 2007--(T-Net)--Angiotech Pharmaceuticals (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its innovative, anti-infective 5-Fluorouracil-coated (5-FU) Central Venous Catheter (CVC).